索引超出了数组界限。
[1] Lundberg AS, Andersen MK, Kasch H, et al. Patients with spinal cord
injuries experience many sequelae[J]. Ugeskr Laeger, 2015, 177(43):
V06150476.
[2] Shende P, Subedi M. Pathophysiology, mechanisms and applications
of mesenchymal stem cells for the treatment of spinal cord injury[J].
Biomed Pharmacother, 2017, 91: 693-706.
[3] Tran AP, Warren PM, Silver J. The biology of regeneration failure
and success after spinal cord injury[J]. Physiol Rev, 2018, 98(2): 881-
917.
[4] Fan B, Wei Z, Feng S. Progression in translational research on spinal
cord injury based on microenvironment imbalance[J]. Bone Res,
2022, 10(1): 35.
[5] Wang J, Zhang F, Xu H, et al. TLR4 aggravates microglial pyroptosis
by promoting DDX3X-mediated NLRP3 inflammasome activation
via JAK2/STAT1 pathway after spinal cord injury[J]. Clin Transl
Med, 2022, 12(6): e894.
[6] Luo Z, Peng W, Xu Y, et al. Exosomal OTULIN from M2
macrophages promotes the recovery of spinal cord injuries
via stimulating Wnt/β-catenin pathway-mediated vascular
regeneration[J]. Acta Biomater, 2021, 136: 519-532.
[7] Zhang Y, Qin Y, Chopp M, et al. Ischemic cerebral endothelial cellderived exosomes promote axonal growth[J]. Stroke, 2020, 51(12):
3701-3712.
[8] Anderson MA, Burda JE, Ren Y, et al. Astrocyte scar formation
aids central nervous system axon regeneration[J]. Nature, 2016,
532(7598): 195-200.
[9] Pan D, Li Y, Yang F, et al. Increasing toll-like receptor 2 on
astrocytes induced by Schwann cell-derived exosomes promotes
recovery by inhibiting CSPGs deposition after spinal cord injury[J].
J Neuroinflammation, 2021, 18(1): 172.
[10] Lee M, Ban JJ, Yang S, et al. The exosome of adipose-derived stem
cells reduces β-amyloid pathology and apoptosis of neuronal cells
derived from the transgenic mouse model of Alzheimer's disease[J].
Brain Res, 2018, 1691: 87-93.
[11] Xiao Y, Geng F, Wang G, et al. Bone marrow-derived mesenchymal
stem cells-derived exosomes prevent oligodendrocyte apoptosis
through exosomal miR-134 by targeting caspase-8[J]. J Cell Biochem,
2018, [Epub ahead of print].
[12] Fan H, Chen Z, Tang HB, et al. Exosomes derived from olfactory
ensheathing cells provided neuroprotection for spinal cord injury by
switching the phenotype of macrophages/microglia[J]. Bioeng Transl
Med, 2021, 7(2): e10287.
[13] Zhou Z, Li C, Bao T, et al. Exosome-shuttled miR-672-5p from
anti-inflammatory microglia repair traumatic spinal cord injury
by inhibiting AIM2/ASC/Caspase-1 signaling pathway mediated
neuronal pyroptosis[J]. J Neurotrauma, 2022, 39(15-16): 1057-1074.
[14] Sun G, Li G, Li D, et al. hucMSC derived exosomes promote
functional recovery in spinal cord injury mice via attenuating
inflammation[J]. Mater Sci Eng C Mater Biol Appl, 2018, 89: 194-
204.
[15] Chen L, Wang W, Lin Z, et al. Conducting molybdenum sulfide/
graphene oxide/polyvinyl alcohol nanocomposite hydrogel for
repairing spinal cord injury[J]. J Nanobiotechnology, 2022, 20(1):
210.
[16] Safari B, Aghazadeh M, Davaran S, et al. Exosome-loaded hydrogels:
a new cell-free therapeutic approach for skin regeneration[J]. Eur J
Pharm Biopharm, 2022, 171: 50-59.
[17] Zhang K, Feng Q, Fang Z, et al. Structurally dynamic hydrogels
for biomedical applications: pursuing a fine balance between
macroscopic stability and microscopic dynamics[J]. Chem Rev, 2021,
121(18): 11149-11193.
[18] Guo B, Ma PX. Conducting polymers for tissue engineering[J].
Biomacromolecules, 2018, 19(6): 1764-1782.
[19] Li X, Zhang C, Haggerty AE, et al. The effect of a nanofiber-hydrogel
composite on neural tissue repair and regeneration in the contused
spinal cord[J]. Biomaterials, 2020, 245: 119978.
[20] Piantanida E, Alonci G, Bertucci A, et al. Design of nanocomposite
injectable hydrogels for minimally invasive surgery[J]. Acc Chem
Res, 2019, 52(8): 2101-2112.
[21] Fan L, Liu C, Chen X, et al. Exosomes-loaded electroconductive
hydrogel synergistically promotes tissue repair after spinal cord
injury via immunoregulation and enhancement of myelinated axon
growth[J]. Adv Sci (Weinh), 2022, 9(13): e2105586.
[22] Cheng J, Chen Z, Liu C, et al. Bone mesenchymal stem cell-derived
exosome-loaded injectable hydrogel for minimally invasive treatment
of spinal cord injury[J]. Nanomedicine (Lond), 2021, (18): 1567-
1579.
[23] Li L, Zhang Y, Mu J, et al. Transplantation of human mesenchymal
stem-cell-derived exosomes immobilized in an adhesive hydrogel for
effective treatment of spinal cord injury[J]. Nano Lett, 2020, 20(6):
4298-4305.
[24] Mukhamedshina YO, Akhmetzyanova ER, Kostennikov AA, et al.
Adipose-derived mesenchymal stem cell application combined with
fibrin matrix promotes structural and functional recovery following
spinal cord injury in rats[J]. Front Pharmacol, 2018, 9: 343.
[25] Zaviskova K, Tukmachev D, Dubisova J, et al. Injectable
hydroxyphenyl derivative of hyaluronic acid hydrogel modified with
RGD as scaffold for spinal cord injury repair[J]. J Biomed Mater Res
A, 2018, 106(4): 1129-1140.
[26] Yao M, Li J, Zhang J, et al. Dual-enzymatically cross-linked gelatin
hydrogel enhances neural differentiation of human umbilical cord
mesenchymal stem cells and functional recovery in experimental
murine spinal cord injury[J]. J Mater Chem B, 2021, 9(2): 440-452.
[27] Drobnik J, Pietrucha K, Kudzin M, et al. Comparison of various types
of collagenous scaffolds applied for embryonic nerve cell culture[J].
Biologicals, 2017, 46: 74-80.
[28] Santi S, Corridori I, Pugno NM, et al. Injectable scaffold-systems for
the regeneration of spinal cord: advances of the past decade[J]. ACS
Biomater Sci Eng, 2021, 7(3): 983-999.
[29] Raghav PK, Mann Z, Ahlawat S, et al. Mesenchymal stem cellbased
nanoparticles and scaffolds in regenerative medicine[J]. Eur J
Pharmacol, 2022, 918: 174657.
[30] Barjesteh T, Mansur S, Bao Y. Inorganic nanoparticle-loaded
exosomes for biomedical applications[J]. Molecules, 2021, 26(4):
1135.
[31] Yu Y, Yang T, Sun T. New insights into the synthesis, toxicity and
applications of gold nanoparticles in CT imaging and treatment of
cancer[J]. Nanomedicine (Lond), 2020, 15(11): 1127-1145.
[32] Chang M, Chang YJ, Chao PY, et al. Exosome purification based
on PEG-coated Fe3O4 nanoparticles[J]. PLoS One, 2018, 13(6):
e0199438.
[33] Azizi M, Farahmandghavi F, Joghataei MT, et al. ChABC-loaded
PLGA nanoparticles: a comprehensive study on biocompatibility,
functional recovery, and axonal regeneration in animal model of
spinal cord injury[J]. Int J Pharm, 2020, 577: 119037.
[34] Han GH, Ko WK, Kim SJ, et al. Neuron-inducing therapy using
embryonic neural progenitor cells embedding positively charged gold
nanoparticles in rats with complete spinal cord injury[J]. Clin Transl
Med, 2022, 12(7): e981.
[35] Kim HY, Kumar H, Jo MJ, et al. Therapeutic efficacy-potentiated and
diseased organ-targeting nanovesicles derived from mesenchymal
stem cells for spinal cord injury treatment[J]. Nano Lett, 2018, 18(8):
4965-4975.
[36] He W, Zhang X, Li X, et al. A decellularized spinal cord extracellular
matrix-gel/GelMA hydrogel three-dimensional composite scaffold
promotes recovery from spinal cord injury via synergism with human
menstrual blood-derived stem cells[J]. J Mater Chem B, 2022, 10(30):5753-5764.
[37] Haggerty AE, Maldonado-Lasunción I, Nitobe Y, et al. The effects
of the combination of mesenchymal stromal cells and nanofiberhydrogel
composite on repair of the contused spinal cord[J]. Cells,
2022, 11(7):1137.
[38] Zarepour A, Bal ?ztürk A, Koyuncu Irmak D, et al. Combination
therapy using nanomaterials and stem cells to treat spinal cord
injuries[J]. Eur J Pharm Biopharm, 2022, 177: 224-240.
[39] Koffler J, Zhu W, Qu X, et al. Biomimetic 3D-printed scaffolds for
spinal cord injury repair[J]. Nat Med, 2019, 25(2): 263-269.